Leukotriene C4 synthase: A pivotal enzyme in cellular biosynthesis of the cysteinyl leukotrienes

Prostaglandins and Other Lipid Mediators

Volumn 68-69, Issue , 2002, Pages 511-520

  Lam, Bing K ^a   Frank Austen, K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Conjugation; Inflammation; Leukotriene C4; Mutagenesis

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN INHIBITOR; COBALT; COMPLEMENTARY DNA; GLUTATHIONE TRANSFERASE; ISOENZYME; LEUKOTRIENE A4; LEUKOTRIENE C4; LEUKOTRIENE C4 SYNTHASE; MAGNESIUM ION; MEMBRANE PROTEIN; PEPTIDOLEUKOTRIENE; PROTEIN INHIBITOR; TATA BINDING PROTEIN; THIOL DERIVATIVE; TYROSINE; UNCLASSIFIED DRUG; CYSTEINE; LEUKOTRIENE; LEUKOTRIENE-C4 SYNTHASE;

AMINO ACID SEQUENCE; ARTICLE; BODY GROWTH; CATALYSIS; CONJUGATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME SPECIFICITY; EXON; FATTY ACID SYNTHESIS; GENE CONSTRUCT; GENE DISRUPTION; GENETIC ORGANIZATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INTRON; NONHUMAN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN SECONDARY STRUCTURE; REPORTER GENE; SEQUENCE HOMOLOGY; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION; ANIMAL; ASTHMA; CHEMICAL STRUCTURE; CHEMISTRY; ENZYME ACTIVE SITE; GENE EXPRESSION REGULATION; GENE TARGETING; GENETICS; METABOLISM; REVIEW;

ANIMALS; ASTHMA; CATALYTIC DOMAIN; CYSTEINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE TARGETING; GLUTATHIONE TRANSFERASE; HUMANS; LEUKOTRIENES; MOLECULAR STRUCTURE;

EID: 0036669584     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(02)00052-7     Document Type: Article

References (47)

1. Busse W.W., Calhun W.F., Sedgwick J.D. Mechanism of airway inflammation in asthma. Am. Rev. Respir. Dis.147:1993;S20-S24.
2. Dunnill M.S. The pathology of asthma, with special reference to changes in the bronchial mucosa. J. Clin. Path. 13:1960;27-33.
3. Laitinen L.A., Heino M., Laitinen A., Kava T., Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am. Rev. Respir. Dis. 131:1985;599-606.
4. Roche W.R., Beasley R., Williams J.H., Holgate S.T. Subepithelial fibrosis in the bronchi of asthmatics. Lancet. 1:1989;520-524.
5. Beasley R., Roche W.R., Roberts J.A., Holgate S.T. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am. Rev. Respir. Dis. 139:1989;806-817.
6. Robinson D.S., Hamid Q., Ying S., Tsicopoulos A., Barkan J., Bentley A.M.et al. Predominant Th2-like brochoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:1992;298-304.
7. 4, methacholine, and histamine. Am. Rev. Respir. Dis. 142:1990;1112-1118.
8. Drazen J.M., Austen K.F. Leukotrienes and airway responses. Am. Rev. Respir. Dis. 136:1987;985-998.
9. Lam S., Chan H., LeRiche J.C., Chan-Yeung M., Salari H. Release of leukotrienes in patients with bronchial asthma. J. Allergy Clin. Immunol. 81:1988;711-717.
10. 4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am. Rev. Respir. Dis. 142:1990;112-119.
11. Pliss L.B., Ingenito E.P., Ingram R.H., Pichurko B. Assessment of broncho-alveolar cell and mediator response to isocapnic hyperpnea in asthma. Am. Rev. Respir. Dis. 142:1990;73-78.
12. 4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am. Rev. Respir. Dis. 143:1991;1025-1029.
13. 4) receptor antagonist (MK-571) in a patient with asthma. Am. Rev. Respir. Dis. 146:1992;358-363.
14. 4-receptor agonist. N. Engl. J. Med. 323:1990;1736-1739.
15. Israel E., Dermarkarian R., Rosenberg M., Sperling R., Taylor G., Rubin P.et al. The effects of 5-lipoxygenase inhibitor. N. Engl. J. Med. 323:1990;1740-1744.
16. Taylor I.K., O'Shaughnessy K.M., Fuller R.W., Dollery C.T. Effect of cysteinyl-leukotriene receptor antagonist ICI 204,219 on allergen induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet. 337:1991;690-694.
17. Israel E., Fischer A.R., Rosenberg M.A., Lilly C.M., Callery J.C., Shapiro J.et al. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-induced asthma. Am. Rev. Respir. Dis. 148:1993;1447-1451.
18. Israel E., Rubin P., Kemp J.P., Grossman J., Pierson W., Siegal S.C.et al. The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma. Ann. Int. Med. 119:1993;1059-1066.
19. 2 from human monocytic cell line U937. Proc. Natl. Acad. Sci. U.S.A. 87:1990;7708-7712.
20. Brock T.G., McNish R.W., Bailie M.B., Peters-Golden M. Rapid import of cytosolic 5-lipoxygenase into the nucleus of neutrophils after in vivo recruitment and in vitro adherence. J. Biol. Chem. 272:1997;8276-8280.
21. Lepley R.A., Muskardin D.T., Fitzpatrick F.A. Tyrosine kinase activity modulates catalysis and translocation of cellular 5-lipoxygenase. J. Biol. Chem. 271:1996;6179-6184.
22. 4 synthase activities. Proc. Natl. Acad. Sci. U.S.A. 83:1986;857-861.
23. 4 synthase of guinea pig lung. J. Clin. Invest. 81:1988;866-871.
24. 4 by human eosinophils. J. Biol. Chem. 264:1989;12885-12889.
25. 4. Biochem. Biophys. Res. Commun. 130:1985;214-220.
26. 1 receptor. Nature. 399:1999;789-793.
27. Heise C.E., O'Dowd B.F., Figueroa D.J., Sawyer N., Nguyen T., Im D.S.et al. Characterization of the human cysteinyl leukotriene 2 receptor. J. Biol. Chem. 275:2000;30531-30536.
28. Mellor E.A., Maekawa A., Austen K.F., Boyce J.A. Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells. Proc. Natl. Acad. Sci. U.S.A. 98:2001;7964-7969.
29. Bach M.K., Brashler J.R., Peck R.E., Morton D.R. Jr. Leukotriene C synthetase, a special glutathione S-transferase: properties of the enzyme and inhibitor studies with special reference to the mode of action of U-60257, a selective inhibitor of leukotriene synthesis. J. Allergy Clin. Immunol. 74:1984;353-357.
30. 4 synthase from dimethylsulfoxide-differentiated U-937 cells. Eur. J. Biochem. 209:1992;725-734.
31. 4 synthase: a glutathione S-transferase composed of 18-kDa subunits. Proc. Natl. Acad. Sci. U.S.A. 90:1993;2015-2019.
32. 4 synthase. J. Biol. Chem. 272:1997;13923-13928.
33. 4. Proc. Natl. Acad. Sci. U.S.A. 91:1994;7663-7667.
34. 4 synthase. Eur. J. Biochem. 238:1996;606-612.
35. 4 synthase activity in human granulocytes. FEBS Lett. 377:1995;87-91.
36. Jakobsson P.J., Morgenstern R., Mancini J., Ford-Hutchinson A.W., Persson B. Common structural features of MAPEG: a widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid. Science. 8:1999;689-692.
37. 4 synthase: organization, nucleotide sequence, and chromosomal localization to 5q35. J. Biol. Chem. 271:1996;11356-11361.
38. 4 synthase. Eur. J. Biochem. 248:1997;807-813.
39. van Leeuwen B.H., Martinson M.E., Webb G.C., Young I.G. Molecular organization of the cytokine gene cluster, involving the human IL-3, IL-4, IL-5, and GM-CSF genes, on human chromosome 5. Blood. 73:1989;1142-1148.
40. 4 synthase involves a Kruppel-like transcription factor and Sp1. J. Biol. Chem. 275:2000;8903-8910.
41. 4 synthase polymorphism and risk of aspirin-induced asthma. Lancet. 350:1997;1599-1600.
42. 4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States. J. Allergy Clin. Immunol. 106:2000;72-76.
43. 4 synthase activity in differentiating human erythroleukemia cells. Biochem. Biophys. Res. Commun. 189:1992;1043-1049.
44. 4 synthase expression in the monocyte-like cell line, THP-1. J. Immunol. 162:1999;1101-1107.
45. 4 synthase during the development of eosinophils in vitro from cord blood progenitors. Blood. 88:1996;4338-4347.
46. 4 synthase expression by interleukin 4. J. Exp. Med. 193:2001;123-133.
47. 4 synthase. J. Biol. Chem. 276:2001;22608-22613.